UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 300

Sortiert nach

Early hemostatic responses to trauma identified with hierarchical clustering analysis

Journal of thrombosis and haemostasis, 2015-06, Vol.13 (6), p.978-988

2015

Volltextzugriff (PDF)

Allosterism‐based simultaneous, dual anticoagulant and antiplatelet action: allosteric inhibitor targeting the glycoprotein Ibα‐binding and heparin‐binding site of thrombin

Journal of thrombosis and haemostasis, 2016-04, Vol.14 (4), p.828-838

2016

Volltextzugriff (PDF)

Failure of corn trypsin inhibitor to affect the thrombin generation assay in plasma from severe hemophiliacs

Journal of thrombosis and haemostasis, 2014-09, Vol.12 (9), p.1558-1561

2014

Volltextzugriff (PDF)

Pharmacokinetic Interaction between Amprenavir and Rifabutin or Rifampin in Healthy Males

Antimicrobial Agents and Chemotherapy, 2001-02, Vol.45 (2), p.502-508

2001

Volltextzugriff (PDF)

Recombinant human factor VIIa (rFVIIa) cleared principally by antithrombin following intravenous administration in hemophilia patients

Journal of thrombosis and haemostasis, 2011-02, Vol.9 (2), p.333-338

2011

Volltextzugriff (PDF)

Is some better than none: are TEG and TGA profiles different in severe FVIII-deficient patients with inhibitors?

Haemophilia : the official journal of the World Federation of Hemophilia, 2015-05, Vol.21 (3), p.398-404

2015

Volltextzugriff (PDF)

The Pharmacokinetics of Subcutaneous Enoxaparin in End-Stage Renal Disease

Pharmacotherapy, 2001-02, Vol.21 (2), p.169-174

2001

Volltextzugriff (PDF)

Monitoring rFVIII prophylaxis dosing using global haemostasis assays

Haemophilia : the official journal of the World Federation of Hemophilia, 2013-05, Vol.19 (3), p.409-414

2013

Volltextzugriff (PDF)

Modulation of the activated protein C pathway in severe haemophilia A patients: The effects of thrombomodulin and a factor V‐stabilizing fab

Haemophilia : the official journal of the World Federation of Hemophilia, 2017-11, Vol.23 (6), p.941-947

2017

Volltextzugriff (PDF)

Antifactor Xa activity correlates to thrombin generation time, platelet contractile force and clot elastic modulus following ex vivo enoxaparin exposure in patients with and without renal dysfunction

Journal of thrombosis and haemostasis, 2004-08, Vol.2 (8), p.1299-1304

2004

Volltextzugriff (PDF)

Pharmacokinetic Interaction between Amprenavir and Clarithromycin in Healthy Male Volunteers

Antimicrobial Agents and Chemotherapy, 2000-04, Vol.44 (4), p.978-984

2000

Volltextzugriff (PDF)

Thrombin generation time is a novel parameter for monitoring enoxaparin therapy in patients with end‐stage renal disease

Journal of thrombosis and haemostasis, 2006-02, Vol.4 (2), p.372-376

2006

Volltextzugriff (PDF)

Coated platelet assay: a feasible approach to a complicated science

Haemophilia : the official journal of the World Federation of Hemophilia, 2016-01, Vol.22 (1), p.e67-e70

2016

Volltextzugriff (PDF)

Amiloride for the prevention of amphotericin B-induced hypokalemia and hypomagnesemia

The Annals of pharmacotherapy, 2000-01, Vol.34 (1), p.94

2000

Volltextzugriff (PDF)

Monitoring rFVIIa 90 μg kg(-1) dosing in haemophiliacs: comparing laboratory response using various whole blood assays over 6 h

Haemophilia : the official journal of the World Federation of Hemophilia, 2011-09, Vol.17 (5), p.949

2011

Volltextzugriff (PDF)

Effect of recombinant factor VIIa variant (NN1731) on platelet function, clot structure and force onset time in whole blood from healthy volunteers and haemophilia patients

Haemophilia : the official journal of the World Federation of Hemophilia, 2007-09, Vol.13 (5), p.533-541

2007

Volltextzugriff (PDF)

Monitoring rFVIIa 90 μg kg−1 dosing in haemophiliacs: comparing laboratory response using various whole blood assays over 6 h

Haemophilia : the official journal of the World Federation of Hemophilia, 2011-09, Vol.17 (5), p.e949-e957

2011

Volltextzugriff (PDF)

The Pharmacokinetics and Pharmacodynamics of Losartan in Continuous Ambulatory Peritoneal Dialysis

Journal of clinical pharmacology, 2000-04, Vol.40 (4), p.389-395

2000

Volltextzugriff (PDF)

Small and middle molecular weight solute clearance in nocturnal intermittent peritoneal dialysis

Peritoneal dialysis international, 1999-11, Vol.19 (6), p.534-539

1999

Volltextzugriff (PDF)

Nonsteroidal antiinflammatory drug-induced hepatitis

The Annals of pharmacotherapy, 1998-03, Vol.32 (3), p.386

1998

Volltextzugriff (PDF)

Automated peritoneal dialysis: new implications for pharmacists

The Annals of pharmacotherapy, 1997-06, Vol.31 (6), p.756

1997

Volltextzugriff (PDF)

Allosterism-based simultaneous, dual anticoagulant and antiplatelet action: allosteric inhibitor targeting the glycoprotein Ib[alpha]-binding and heparin-binding site of thrombin

Journal of thrombosis and haemostasis, 2016-04, Vol.14 (4), p.828

2016

Volltextzugriff (PDF)

Continuous-Flow Left Ventricular Assist Device–Related Gastrointestinal Bleeding

Cardiology clinics, 2018-11, Vol.36 (4), p.519-529

2018

Volltextzugriff (PDF)

Modulation of the activated protein C pathway in severe haemophilia A patients: The effects of thrombomodulin and aￂ factor V-stabilizing fab

Haemophilia : the official journal of the World Federation of Hemophilia, 2017-11, Vol.23 (6), p.941

2017

Volltextzugriff (PDF)

Warfarin Resistance in a Patient with Short Bowel Syndrome

Pharmacotherapy, 1998-05, Vol.18 (3), p.646-649

1998

Volltextzugriff (PDF)

1 – 25 von 300

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(285)
Mit Volltextzugriff
(268)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Early hemostatic responses to trauma identified with hierarchical clustering analysis

Allosterism‐based simultaneous, dual anticoagulant and antiplatelet action: allosteric inhibitor targeting the glycoprotein Ibα‐binding and heparin‐binding site of thrombin

Failure of corn trypsin inhibitor to affect the thrombin generation assay in plasma from severe hemophiliacs

Pharmacokinetic Interaction between Amprenavir and Rifabutin or Rifampin in Healthy Males

Recombinant human factor VIIa (rFVIIa) cleared principally by antithrombin following intravenous administration in hemophilia patients

Is some better than none: are TEG and TGA profiles different in severe FVIII-deficient patients with inhibitors?

The Pharmacokinetics of Subcutaneous Enoxaparin in End-Stage Renal Disease

Monitoring rFVIII prophylaxis dosing using global haemostasis assays

Modulation of the activated protein C pathway in severe haemophilia A patients: The effects of thrombomodulin and a factor V‐stabilizing fab

Antifactor Xa activity correlates to thrombin generation time, platelet contractile force and clot elastic modulus following ex vivo enoxaparin exposure in patients with and without renal dysfunction

Pharmacokinetic Interaction between Amprenavir and Clarithromycin in Healthy Male Volunteers

Thrombin generation time is a novel parameter for monitoring enoxaparin therapy in patients with end‐stage renal disease

Coated platelet assay: a feasible approach to a complicated science

Amiloride for the prevention of amphotericin B-induced hypokalemia and hypomagnesemia

Monitoring rFVIIa 90 μg kg(-1) dosing in haemophiliacs: comparing laboratory response using various whole blood assays over 6 h

Effect of recombinant factor VIIa variant (NN1731) on platelet function, clot structure and force onset time in whole blood from healthy volunteers and haemophilia patients

Monitoring rFVIIa 90 μg kg−1 dosing in haemophiliacs: comparing laboratory response using various whole blood assays over 6 h

The Pharmacokinetics and Pharmacodynamics of Losartan in Continuous Ambulatory Peritoneal Dialysis

Small and middle molecular weight solute clearance in nocturnal intermittent peritoneal dialysis

Nonsteroidal antiinflammatory drug-induced hepatitis

Automated peritoneal dialysis: new implications for pharmacists

Allosterism-based simultaneous, dual anticoagulant and antiplatelet action: allosteric inhibitor targeting the glycoprotein Ib[alpha]-binding and heparin-binding site of thrombin

Continuous-Flow Left Ventricular Assist Device–Related Gastrointestinal Bleeding

Modulation of the activated protein C pathway in severe haemophilia A patients: The effects of thrombomodulin and aￂ factor V-stabilizing fab

Warfarin Resistance in a Patient with Short Bowel Syndrome

Suchergebnisse filtern